KENNETH FRAZIER RESIGNS AS CEO OF PHARMA COMPANY MERCK & CO

Highlights

• Chief Executive Officer (CEO) Kenneth Frazier has decided to step down from his post at the end of June and will be replaced by the Chief Financial Officer Robert Davis

• The drugmaker said Frazier, 66, will continue to serve on its board as executive ch...